TR200907914A2 - Pharmaceutical composition in the form of a dry powder containing corticosteroid. - Google Patents

Pharmaceutical composition in the form of a dry powder containing corticosteroid.

Info

Publication number
TR200907914A2
TR200907914A2 TR2009/07914A TR200907914A TR200907914A2 TR 200907914 A2 TR200907914 A2 TR 200907914A2 TR 2009/07914 A TR2009/07914 A TR 2009/07914A TR 200907914 A TR200907914 A TR 200907914A TR 200907914 A2 TR200907914 A2 TR 200907914A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
dry powder
powder containing
containing corticosteroid
corticosteroid
Prior art date
Application number
TR2009/07914A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/07914A priority Critical patent/TR200907914A2/en
Priority to PCT/TR2010/000208 priority patent/WO2011049539A1/en
Publication of TR200907914A2 publication Critical patent/TR200907914A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, p2-agonistleri ve kortikosteroit ilaçların yanısıra farmasötik etkinlik gösteren miktarlarda kromoglisik asit ve/veya nedokromil tuzlarını içeren kum toz formundaki farmasötik kompozisyonlara ilişkindir.The present invention relates to pharmaceutical compositions in sand powder form, for use in respiratory tract ailments, containing 2-agonists and corticosteroid drugs, as well as cromoglycic acid and / or nedocromil salts in pharmaceutically effective amounts.

TR2009/07914A 2009-10-20 2009-10-20 Pharmaceutical composition in the form of a dry powder containing corticosteroid. TR200907914A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/07914A TR200907914A2 (en) 2009-10-20 2009-10-20 Pharmaceutical composition in the form of a dry powder containing corticosteroid.
PCT/TR2010/000208 WO2011049539A1 (en) 2009-10-20 2010-10-20 Compositions comprising a corticosteroid, a beta2 agonist as well as cromoglicic acid or ndeocromil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/07914A TR200907914A2 (en) 2009-10-20 2009-10-20 Pharmaceutical composition in the form of a dry powder containing corticosteroid.

Publications (1)

Publication Number Publication Date
TR200907914A2 true TR200907914A2 (en) 2011-05-23

Family

ID=43734282

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/07914A TR200907914A2 (en) 2009-10-20 2009-10-20 Pharmaceutical composition in the form of a dry powder containing corticosteroid.

Country Status (2)

Country Link
TR (1) TR200907914A2 (en)
WO (1) WO2011049539A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201321712D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
ES2653787B1 (en) * 2016-07-07 2018-09-25 Diater Laboratorio De Diagnóstico Y Aplicaciones Terapéuticas, S.A. CHROMOGLITIC ACID COMPOSITIONS FOR THE TREATMENT OF DERMATITIS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8911259D0 (en) * 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
CA2125666C (en) * 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
ES2193726T3 (en) 1998-08-04 2003-11-01 Jago Res Ag MEDICINAL AEROSOL FORMULATIONS.

Also Published As

Publication number Publication date
WO2011049539A1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
CY1120605T1 (en) DRY POWDER PREPARATION INCLUDING A PHOSPHODIESTERATION INHIBITOR
GT201400016A (en) INDAZOLES
IL227594A (en) Substituted aminobutyric derivatives as neprilysin inhibitors, process for their preparation, pharmaceutical compositions comprising them and use thereof for preparation of medicaments
IL230458A (en) Heterocyclic substituted 2-methylbenzimidazole derivatives, pharmaceutical compositions comprising them and their use for manufacture of medicaments for treatment and prophylaxis of respiratory syncytial virus disease
UA109010C2 (en) Morpholino pyrividines and their use in therapy
EA201491060A1 (en) NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE
UA106636C2 (en) MORPHOLINOTIAZOLES AS A POSITIVE ALLOSTERIC ALPHA MODULATORS 7
TR201000733A2 (en) Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate.
CO7160008A2 (en) Derivatives of estra- 1,3,5 (10), 3-substituted 16-tetraene, methods for their preparation, pharmaceutical preparations containing them, as well as their use for the preparation of medicines
BR112015007647A2 (en) ketamine derivatives
BR112015018071A2 (en) estra-1,3,5 (10), 16-tetraene-3-carboxamides
BR112015027017A2 (en) inhalable pharmaceutical compositions and inhaler devices containing the same
TR201000681A2 (en) Dry powder formulations inhaled.
PH12014501545A1 (en) Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
TR200907917A2 (en) Dry powder inhaler.
BR112014009580A2 (en) omeprazole pharmaceutical composition
CY1115266T1 (en) PHARMACEUTICAL COMPOSITIONS OF FORMOTEROL AND DIPROPIONATE VECLOMETHASONE
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
TR200907914A2 (en) Pharmaceutical composition in the form of a dry powder containing corticosteroid.
CL2013003556A1 (en) Phthalazinone-pyrrolo [3,2-d] pyrimidine-carboxamide derivatives, phosphodiesterase type 4 and type 5 inhibitors; pharmaceutical composition that comprises or fixed combination, not fixed and kit, use of the compound in the preparation of a medicament for treating respiratory tract diseases
TR200907913A2 (en) Pharmaceutical composition in dry powder form for inhalation
TR200909792A2 (en) Dry powder combination containing tiotropium, corticosteroid and a combination of chromoglycic acid derivative
TR200907915A2 (en) Pharmaceutical composition in dry powder form.
TR200909793A2 (en) Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative.